instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: As part of President Barack Obama's healthcare reform law, the efforts center around more than 360 accountable care organizations (ACOs), which are networks of doctors, hospitals and other providers specially organized to help move Medicare away from traditional fee-for-service medicine. The U.S. Centers for Medicare and Medicaid Services (CMS) said preliminary data show that the ACOs produced $380 million in savings vis-a-vis traditional Medicare in 2012 by giving doctors and other healthcare providers the incentive to focus on improved outcomes for patients instead of fees from tests and services. Medicare, the $575 billion government healthcare system for 51 million elderly and disabled beneficiaries, faces growing financial pressures as a result of America's aging population. A mainstay, the trust fund that pays for hospitalization, is expected to be exhausted in 2026. Deficit hawks view Medicare as a future driver of the federal debt and have called for major systemic reforms. But the Obama administration has pursued gradual changes including the reform of care delivery systems. So-called fee-for-service medicine is widely viewed as a cause of rising healthcare costs, because it calls for paying healthcare providers for tests and services that are sometimes unnecessary. Obamacare seeks to tackle costs by exploring ACOs and other new healthcare business models intended to find savings that do not jeopardize care. A main goal is to generate savings large enough to be shared between Medicare and providers. But some experts are skeptical, saying significant cost reductions could be hard to maintain over time. But CMS, an agency within the U.S. Department of Health and Human Services, runs two different ACO programs. In its largest, 54 of 114 ACO networks achieved lower than expected expenditures. But only 29 saw savings big enough to share with providers. All told, the program produced $128 million in net savings for Medicare's trust funds. "Overall, the ACO program's a net saver to the Medicare program," CMS principal deputy administrator Jon Blum told reporters in a conference call. "It's giving us great confidence that this is the right course for the Medicare program and we are confident that it will continue to show quality improvement and cost savings." Officials said the ACOs also achieved a wide range of quality goals. But CMS released no quality statistics. Thursday's government release drew some cautious optimism from the healthcare industry. "Today's report reflects important steps. More work is needed to modernize our antiquated Medicare payment system and base payment on evidence-based quality measures and proven patient outcomes," said Dr. John Noseworthy, chief executive of the Mayo Clinic in Rochester, Minnesota, which is not part of the government's program. "As results of the team-based care models are analyzed, those most effective in driving down health care costs without compromising safety and quality should become part of the healthcare system," he said. Claim: U.S. says results encouraging for healthcare delivery reforms.
answer:
The Obama administration on Thursday reported what it called encouraging results from efforts to reduce healthcare costs and improve the quality of care for more than 5 million Medicare beneficiaries under Obamacare

question:
Paragraph: Data from the 236-patient trial, which lasted 13 weeks and compared the effectiveness of Cymbalta with placebos, were presented at the annual congress of the European Federation of Neurological Societies in Madrid. Lilly said 31 percent of patients taking Cymbalta experienced a 50 percent reduction in pain, as measured by a standard pain scale, compared with 19 percent of placebo-treated patients. But significantly more patients taking Cymbalta dropped out of the trial because of side effects, which included nausea, dry mouth, fatigue, diarrhea, excessive sweating, dizziness and constipation. Lilly said side effects were similar to those seen in previous trials of Cymbalta for other conditions. Global second-quarter sales of Cymbalta, one of Lilly's biggest products, jumped 26 percent to $654 million, helped by its other approved uses to treat fibromyalgia and generalized anxiety disorder. The drug works by maximizing the presence of two messenger chemicals in the brain, serotonin and norepinephrine. Claim: Lilly depression drug eases back pain in study.
answer:
Eli Lilly and Co's Cymbalta depression treatment significantly reduced chronic low back pain in a relatively small clinical trial, the company said on Monday.

question:
Paragraph: Health Ministry official Achmad Yurianto said there had been 106 new confirmed infections, taking the total number of cases in the Southeast Asian country to 2,092, with 10 new deaths. "We are still on high alert over infections that are taking place in the community that are caused by positive cases among people who are not showing symptoms," said Yurianto. Indonesia is relying mainly on social distancing policies to combat the virus since President Joko Widodo has opposed the harsh lockdown measures adopted in many neighboring countries. The country reported its first case of the virus a month ago, but epidemiologists say a relatively low level of testing means the number of cases may be vastly under-reported. Indonesia has almost doubled tests in the past week but has conducted only 7,896 tests in a country of more than 260 million people. According to a Reuters review of statistics from Jakarta's Department of Parks and Cemeteries, there were nearly 4,400 funerals in the city in March, 40 percent higher than any month since at least January, 2018. The city has been at the epicenter of COVID-19 infections in Indonesia, accounting for 1,028 cases and around 90 deaths, according to central government data, or roughly half the country's total for both. Jakarta's governor, Anies Baswedan, and some public health experts suspect the number of infections and deaths in the city has been significantly under-reported due to the low rates of testing. "It is extremely disturbing," Baswedan told Reuters on Friday, referring to the funeral statistics. "I'm struggling to find another reason than unreported COVID-19 deaths." Officials at the health ministry and at the presidential office did not respond to requests for comment. In an interview on Thursday, before Baswedan had made his comments, Yurianto defended the reporting and testing system and said the central government based its data on lab results using the accurate polymerase chain reaction (PCR) method. Claim: Indonesia coronavirus cases top 2,000 amid concerns over data.
answer:
Indonesia said on Saturday that coronavirus cases had topped 2,000 and deaths risen to 191, but doubts have been raised over official figures by data showing a big jump in funerals last month in the capital Jakarta.